Zacks Research Daily highlights new reports on 16 major stocks, including NVIDIA Corp. (NVDA), Roche Holding AG (RHHBY), and Lam Research Corp. (LRCX). The micro-cap research on Tredegar Corp. (TG) and Kewaunee Scientific Corp. (KEQU) is unique, offering insights on small, under-the-radar companies. NVIDIA is benefiting from the growth of AI and accelerated computing, while Roche is diversifying its portfolio through acquisitions. Lam Research is riding on its strength in 3D DRAM and advanced packaging technologies. Tredegar, despite financial strain, is making strategic divestitures to focus on higher-margin operations. Kewaunee Scientific has integrated with Nu Aire to reinforce its U.S. market leadership.
NVIDIA’s shares have outperformed the Zacks Semiconductor – General industry this year, driven by strong growth in AI and high-performance computing. The company is seeing increased demand for generative AI and large language models using GPUs based on NVIDIA’s architectures, resulting in a boost in data center revenues. Collaborations with automakers and tier-one suppliers are also strengthening its presence in the autonomous vehicle space.
Roche’s shares have outperformed the Zacks Large Cap Pharmaceuticals industry this year, driven by high demand for key drugs like Ocrevus and Vabysmo. The company is diversifying its portfolio through acquisitions and collaborations to offset declining sales from legacy drugs. However, pipeline setbacks and disappointing performance in the Diagnostic division remain concerns.
Lam Research’s shares have outperformed the Zacks Electronics – Semiconductors industry this year, fueled by strength in 3D DRAM and advanced packaging technologies. The company’s strategic investments in R&D activities position it well to capitalize on the growing wafer fab equipment spending. However, concerns around global spending on mature nodes and trade tensions pose risks.
Tredegar’s shares have underperformed the Zacks Chemical – Plastic industry, with financial strain due to persistent cash burn and rising debt. The company is focusing on divestitures to sharpen its operations in the U.S. market. Despite challenges, Tredegar’s margin recovery is supported by improved performance in Aluminum Extrusions.
Kewaunee Scientific’s shares have outperformed the Zacks Instruments – Scientific industry, driven by its integration with Nu Aire, which has strengthened its U.S. market leadership. The company’s record order backlog, operational efficiency, and diversified exposure across industries and geographies are supporting revenue visibility and margin expansion.
Read more at Nasdaq: Top Stock Reports for NVIDIA, Roche & Lam Research